Andrew Flintoff hails NHS staff who cared for him after car crash
The former international cricketer visited hospital workers who looked after him in the aftermath of the accident, which he described as 'the lowest I've ever been'.
In December 2022, Flintoff sustained severe injuries while filming at the Dunsfold Aerodrome in Surrey for an episode of BBC show Top Gear.
His surgeon described Flintoff's case as one of the most complex he has ever seen.
The former international cricketer was airlifted to St George's Hospital in Tooting – a major trauma centre.
'I just want to say a massive thank you to all the staff at St George's,' Flintoff said.
'I came here probably the lowest I've ever been, in need of help and the expertise, the love, the compassion they showed me was incredible.
'I'll be eternally grateful – absolute superheroes.'
Recalling the incident, consultant oral and maxillofacial surgeon Jahrad Haq, said: 'I was on call that day and received a phone call from the emergency department consultant.
'A lot of injuries are managed at a more junior level before escalating, so I knew this one was serious.
'Of all the trauma cases I've seen in over 20 years, this was among the most complex.'
Shamim Umarji, consultant trauma and orthopaedic surgeon, said: 'It's very rewarding when patients come back and you get to see them not just as patients, but as people. It's a real privilege.
'When you see their recovery, you remember how important our job is.
'It was wonderful to see Freddie again and his visit gave staff a real boost. He spent a lot of time chatting to everyone and it meant a lot.'
Kate Slemeck, managing director for St George's University Hospitals NHS Foundation Trust, said: 'I'm incredibly proud of the care we provide at St George's.
'It's always heart-warming to hear from patients about the expert care, compassion and kindness they've received from our clinical and support teams, and this shows the lasting impact they have on people, long after they've left hospital.'
During a documentary about the accident, Flintoff described how he used the split-second decision-making from his cricketing days to try to reduce the impact of the crash.
He said he was 'pulled face-down on the runway' for about 50 metres under the car.
The former England star said he thought he had died in the accident.
For months after the crash Flintoff disappeared from public view and would leave his house only for medical appointments
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
World-first gonorrhoea vaccine rolled out across UK amid record levels of infection
England has launched a world-first gonorrhoea vaccination programme, aimed at curbing soaring infection rates and tackling the growing threat of antibiotic-resistant strains. The initiative comes after cases of the sexually transmitted infection (STI) in England reached a record 85,000 in 2023, the highest since records began in 1918. Available free of charge from Monday at sexual health clinics, the jab is being offered to those at highest risk. This includes gay and bisexual men with a recent history of multiple sexual partners or a bacterial STI. The vaccine, an existing jab known as 4CMenB, is currently used to protect against meningococcal B disease, which can cause meningitis and sepsis. It is used in the routine childhood programme and given to babies at eight weeks, 16 weeks and one year. Officials anticipate the programme will save the NHS £7.9 million over the next decade. The programme could prevent up to 100,000 cases of gonorrhoea, according to doctors. The STI disproportionately impacts specific communities, such as those in deprived areas, people of black Caribbean ethnicity, and gay, bisexual and other men who have sex with men, according to the Joint Committee on Vaccination and Immunisation (JCVI). Patients getting the gonorrhoea vaccine will also be offered jabs for mpox, human papillomavirus (HPV), and hepatitis A and B at their appointment. 'Rolling out this world-leading gonorrhoea vaccination programme in sexual health clinics in England represents a major breakthrough in preventing an infection that has reached record levels,' Ashley Dalton, the minister for public health and prevention, said. 'This government's world-first vaccination programme will help turn the tide on infections, as well as tackling head-on the growing threat of antibiotic resistance. 'I strongly encourage anyone who is eligible to come forward for vaccination, to protect not only yourselves but also your sexual partners.'
The Independent
an hour ago
- The Independent
Warning issued to patients who stop using weight-loss jabs
Health chiefs have raised concerns about patients regaining weight after stopping popular weight-loss drugs such as Wegovy and Mounjaro, calling for robust support to prevent them from piling on the pounds again. The National Institute for Health and Care Excellence (Nice), the UK's health watchdog, highlighted research indicating that many individuals regain weight if not adequately supported after ceasing treatment. Nice stressed that those coming off the drugs should be offered "structured advice and follow-up support" to mitigate weight gain. This guidance specifically applies to individuals receiving these treatments through the NHS. However, an estimated 1.5 million people in the UK are currently using weight-loss injections, with the vast majority paying privately. These individuals will not be eligible for NHS support once their treatment concludes. Over the next three years, approximately 240,000 people deemed to have the "greatest need" are anticipated to receive Mounjaro, also known as tirzepatide, via the NHS. The new 'quality standard' from Nice says that NHS patients should be monitored for at least a year after they complete treatment, and extra support should be offered if needed. It emphasises building 'long-term behavioural habits, use self-monitoring tools, and draw on wider support – from online communities to family-led interventions and local activities'. This standard, a type of guidance for the health services in England and Wales, sets out expectations for health providers including how they should support patients. 'Successful weight management doesn't end when medication stops or when someone completes a behavioural programme,' said Professor Jonathan Benger, deputy chief executive and chief medical officer at Nice. 'We know that the transition period after treatment is crucial, and people need structured support to maintain the positive changes they've made. 'This new standard makes sure services provide that vital continuity of care, and it supports the NHS 10 Year Plan to shift from a 'sickness service' to a genuine health service focused on prevention.' Dr Rebecca Payne, chair of Nice's Quality Standards Advisory Committee, added: 'Weight management is a long-term journey, not a short-term fix. 'The evidence is clear that advice and support for maintaining weight after stopping medicines or completing behavioural interventions can help prevent weight regain and enable people to experience lasting benefits. 'We've seen excellent examples of services that already provide comprehensive discharge planning and ongoing support. 'This quality standard will help ensure all healthcare providers adopt these best practices, giving every person the best chance of maintaining their weight management success over the long term. 'This standard ensures healthcare services are equipped to provide that essential ongoing support.' Commenting, Henry Gregg, chief executive of the National Pharmacy Association, said: ' Pharmacies take their responsibilities seriously to provide full wrap around support to patients trying to achieve a healthy weight. 'We know that although medication can be effective in speeding up weight loss in some people, it is not a silver bullet and patients need to make long term lifestyle changes to make their weight loss sustainable. 'The current NHS roll out of weight loss treatment is very small, with only a handful of patients receiving it and it will continue to be the case that the vast majority of eligible patients will be seen by their pharmacy.' Professor Kamila Hawthorne, chairwoman of the Royal College of GPs, said: 'There is no one-size-fits-all approach to tackling obesity – what works for one patient will likely not work for another and, as with any medication, weight-loss drugs do not come without risk. 'It's also the case that patients will likely need support to sustain their weight loss once they stop taking the medication. As such, this is important and sensible guidance from Nice. 'As a college, we've been clear that whilst weight loss medications have significant potential benefits for patients who are struggling to lose weight, they mustn't be seen as a 'silver bullet' and ensuring access to sufficient 'wraparound' services – particularly for when patients come off their medication – will be key to optimal health outcomes.'
Telegraph
an hour ago
- Telegraph
NHS told to help fat jab users keep weight off
The NHS has been told to help people taking weight-loss jabs keep the pounds off once they stop the drugs. New guidance issued by the National Institute for Health and Care Excellence (Nice) said the health service should be helping people for at least one year after they stop the injections. Health officials said many people regain weight after stopping treatment if they are not supported, and those coming off the fat jabs should be offered 'structured advice and follow-up support' to help prevent this. An estimated 1.5 million people are taking weight-loss jabs in the UK, but the vast majority are paying for them privately so will not be eligible for NHS support after they have finished their treatment. It comes after the National Pharmacy Association warned that demand for the jabs was 'unsustainable' and could soon outstrip supply. The new 'quality standard' from Nice says NHS patients should be monitored for at least a year after they complete treatment, and emphasises building 'long-term behavioural habits, use self-monitoring tools, and draw on wider support – from online communities to family-led interventions and local activities'. This guidance for the NHS in England and Wales sets out expectations for health providers including how they should support patients. Prof Jonathan Benger, the deputy chief executive and chief medical officer at Nice, said: 'Successful weight management doesn't end when medication stops or when someone completes a behavioural programme. 'We know that the transition period after treatment is crucial, and people need structured support to maintain the positive changes they've made. 'This new standard makes sure services provide that vital continuity of care, and it supports the NHS 10 year plan to shift from a 'sickness service' to a genuine health service focused on prevention.' The guidance says NHS services should monitor people for weight creeping back up and help implement 'if-then' plans so people know what steps to take if there is weight regain. It also says they should work with the patients on making changes to their daily routines as well as eating and shopping habits. Dr Rebecca Payne, the chair of Nice's Quality Standards Advisory Committee, added: 'Weight management is a long-term journey, not a short-term fix. 'The evidence is clear that advice and support for maintaining weight after stopping medicines or completing behavioural interventions can help prevent weight regain and enable people to experience lasting benefits. 'We've seen excellent examples of services that already provide comprehensive discharge planning and ongoing support. 'This quality standard will help ensure all healthcare providers adopt these best practices, giving every person the best chance of maintaining their weight management success over the long term. 'This standard ensures healthcare services are equipped to provide that essential ongoing support.' Prof Kamila Hawthorne, the chairman of the Royal College of GPs, said: 'There is no one-size-fits-all approach to tackling obesity – what works for one patient will likely not work for another and, as with any medication, weight-loss drugs do not come without risk. 'It's also the case that patients will likely need support to sustain their weight loss once they stop taking the medication. As such, this is important and sensible guidance from Nice. 'As a college, we've been clear that whilst weight-loss medications have significant potential benefits for patients who are struggling to lose weight, they mustn't be seen as a 'silver bullet' and ensuring access to sufficient 'wraparound' services – particularly for when patients come off their medication – will be key to optimal health outcomes.' An NHS spokesman said: 'While these new treatments are excellent at supporting weight loss, they're not a magic bullet and must be paired with wraparound support including advice on healthier diets and physical activity to see sustainable results, so we welcome new guidance on this for local services. 'The NHS is already supporting hundreds of thousands of people to lose weight through our 12-week digital weight management programme, and we are expanding this to 125,000 more people per year, so doubling the number of people who can access it, as part of the 10 year health plan.'
